Ingen pharmaceuticals, UAB revenue, profit

Annual financial information for Ingen pharmaceuticals, UAB

• Non-current assets - assets that will be used by the company for more than a year.
• Current assets - comprise receivables, short-term tangible assets, inventories, prepaid expenses, other receivables, and cash.
• Equity (owner's equity) - this is what remains from the total assets after deducting the sum of liabilities.
• Liabilities - these are the company's long-term and short-term debts to suppliers, employees, creditors, the government, etc.
• Sales revenue - the increase in economic benefits during the reporting period due to the sale of goods and services.
• Profit before taxes - all the company's income minus all the company's expenses.
• Profit before taxes margin - the ratio of profit before taxes to sales revenue.
• Net profit - this is the company's income after deducting all the expenses and taxes.
• Net profit margin - the ratio of net profit to sales revenue. In some cases, the profitability can exceed 100% - this usually happens when the company has other operating income, which is not considered as sales income, because it is obtained from atypical activities. An example would be investment income that is not classified as core business but has a positive effect on the bottom line when calculating net profit. In this case, the profitability can exceed 100%, because the atypical activity of the company brings more income than the sales income of the main activity, from which the profitability is calculated.